Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI

Show full item record



Permalink

http://hdl.handle.net/10138/340176

Citation

Richter , J , Lubking , A , Soderlund , S , Lotfi , K , Markevarn , B , Sjalander , A , Stenke , L , Deneberg , S , Ahlstrand , E , Myhr-Eriksson , K , Panayiotidis , P , Gedde-Dahl , T , Zackova , D , Mayer , J , Olsson-Stromberg , U , Mahon , F-X , Saussele , S , Hjorth-Hansen , H & Koskenvesa , P 2021 , ' Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI ' , Leukemia , vol. 35 , no. 8 , pp. 2416-2418 . https://doi.org/10.1038/s41375-021-01173-w

Title: Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI
Author: Richter, Johan; Lubking, Anna; Soderlund, Stina; Lotfi, Kourosh; Markevarn, Berit; Sjalander, Anders; Stenke, Leif; Deneberg, Stefan; Ahlstrand, Erik; Myhr-Eriksson, Kristina; Panayiotidis, Panayiotis; Gedde-Dahl, Tobias; Zackova, Daniela; Mayer, Jiri; Olsson-Stromberg, Ulla; Mahon, Francois-Xavier; Saussele, Susanne; Hjorth-Hansen, Henrik; Koskenvesa, Perttu
Contributor organization: HUS Comprehensive Cancer Center
Department of Medicine
Hematologian yksikkö
Department of Oncology
Date: 2021-08
Language: eng
Number of pages: 3
Belongs to series: Leukemia
ISSN: 0887-6924
DOI: https://doi.org/10.1038/s41375-021-01173-w
URI: http://hdl.handle.net/10138/340176
Subject: 3122 Cancers
Peer reviewed: No
Rights: cc_by
Usage restriction: openAccess
Self-archived version: publishedVersion


Files in this item

Total number of downloads: Loading...

Files Size Format View
s41375_021_01173_w.pdf 296.9Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record